Evidence map›Paper›PMID 42109570›Full record

ArticleIn silico pharmacology2026

Exploring

Rafaela Molina de Angelo, Michell de Oliveira Almeida, João Pedro Portilho Encide, Henrique Barbosa, Daniel da Silva De Sousa, Aldineia Pereira da Silva, Marina Sena Mendes, Maria Cristina Nonato, Albérico Borges Ferreira Da Silva, João Henrique Ghilardi Lago and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in In silico pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rafaela Molina de AngeloCenter of Natural and Human Sciences (CCNH), Federal University of ABC (UFABC), Santo André, SP Brazil.
Michell de Oliveira AlmeidaFaculty of Pharmaceutical Sciences (FCF), University of São Paulo (USP), São Paulo, SP Brazil.
João Pedro Portilho EncideCenter of Natural and Human Sciences (CCNH), Federal University of ABC (UFABC), Santo André, SP Brazil.
Henrique BarbosaCenter of Natural and Human Sciences (CCNH), Federal University of ABC (UFABC), Santo André, SP Brazil.
Daniel da Silva De SousaSão Carlos Institute of Chemistry (IQSC), University of São Paulo (USP), São Carlos, SP Brazil.
Aldineia Pereira da SilvaSchool of Arts, Sciences and Humanities (EACH), University of São Paulo (USP), São Paulo, SP Brazil.
Marina Sena MendesSchool of Pharmaceutical Sciences at Ribeirao Preto (FCFRP), University of São Paulo (USP), Ribeirão Preto, SP Brazil.
Maria Cristina NonatoSchool of Pharmaceutical Sciences at Ribeirao Preto (FCFRP), University of São Paulo (USP), Ribeirão Preto, SP Brazil.
Albérico Borges Ferreira Da SilvaSão Carlos Institute of Chemistry (IQSC), University of São Paulo (USP), São Carlos, SP Brazil.
João Henrique Ghilardi LagoCenter of Natural and Human Sciences (CCNH), Federal University of ABC (UFABC), Santo André, SP Brazil.
Kathia Maria HonorioCenter of Natural and Human Sciences (CCNH), Federal University of ABC (UFABC), Santo André, SP Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosomiasis is a parasitic disease affecting millions worldwide, highlighting the urgent need for effective treatments. This study investigated a new potential site on Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-026-00628-1.

Indexed as

Biological assaysDihydroorotate dehydrogenaseMolecular dockingMolecular dynamicsNatural productsSchistosomiasis

Identifiers

PMID42109570
PMCPMC13156374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.